Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every funding round, exec hire, M&A move, contract, and sentiment shift on Nucleai — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

Nucleai secures $14 million funding led by M Ventures to advance its spatial AI biomarker for clinical enrollment

PRIVATEApr 03, 2024•about 2 years ago

Amount Raised

$14 Million

ChicagoSoftwareHealth CareArtificial Intelligence

Investors

Sanofi VenturesSection 32M Ventures

Description

Nucleai has secured a $14 million investment led by M Ventures, enabling the deployment of its AI algorithms for the prospective enrollment of patients in clinical trials and accelerating the deployment of Nucleai’s spatial analysis technology.

Company Information

Company

Nucleai

Location

Chicago, Illinois, United States

About

Nucleai is the leading AI-powered spatial biomarker company, driving innovation at the intersection of technology and healthcare. Leveraging military intelligence-grade geospatial analytical methods, it intercepts, interprets, and analyzes complex cellular conversations and spatially oriented interactions within tissue samples, translating them into actionable insights. Nucleai’s platform empowers pathologists and researchers with an AI-powered data-rich action plan, paving the way for more informed decisions in the development of bi-specifics, antibody-drug conjugates (ADCs), and immunotherapy. Nucleai's investors include Section 32, Sanofi, Vertex Ventures, M Ventures, and Debiopharm Innovation Fund. It is headquartered in Israel and Chicago. For more information, please visit www.nucleai.ai.

Predictive Intelligence
Strategic

ML-powered predictions for Nucleai's next move

Learn about Strategic plan

Related People

Suggested for you
1 contact

Sign in to view contact details

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, FundzIQ™ for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies.

Watching Nucleai? See every signal — funding, hires, M&A, contracts, sentiment.

See plans